Expression Analysis and Genomic Convergence in PD

$273,722P50FY2008NSNIH

University Of Miami School Of Medicine, Coral Gables FL

Investigators

Linked publications & trials

Paper 39677464 Paper 39444005 Paper 39371140 Paper 39231932 Paper 38958117 Paper 38942763 Paper 38903124 Paper 38883718 Paper 38712163 Paper 38460116 Paper 38014121 Paper 37745545 Paper 37578203 Paper 37547016 Paper 37260021 Paper 35379992 Paper 35210353 Paper 35142023 Paper 35120553 Paper 34852950 Paper 34526147 Paper 33938021 Paper 32400971 Paper 31270419 Paper 30448613 Paper 30137212 Paper 28714976 Paper 28183528 Paper 27103524 Paper 27066581 Paper 27036079 Paper 26919393 Paper 26827652 Paper 26449541 Paper 26366463 Paper 26092349 Paper 26079503 Paper 26079416 Paper 25778476 Paper 25663231 Paper 25393808 Paper 25199842 Paper 25188341 Paper 24922517 Paper 24573903 Paper 24244562 Paper 24190026 Paper 23845100 Paper 23582655 Paper 23571587 Paper 23565137 Paper 23408866 Paper 23360175 Paper 23227193 Paper 23200709 Paper 23143602 Paper 23034908 Paper 22933317 Paper 22869155 Paper 22761592 Paper 22685416 Paper 22451204 Paper 22442429 Paper 22405046 Paper 22003392 Paper 21876681 Paper 21537449 Paper 21364952 Paper 21309754 Paper 21205674 Paper 20885792 Paper 20837857 Paper 20809526 Paper 20711177 Paper 20573704 Paper 20523261 Paper 20070850 Paper 19521100 Paper 19344875 Paper 19327735 Paper 18789830 Paper 18714388 Paper 18663495 Paper 18373838 Paper 18278816 Paper 18271029 Paper 18252210 Paper 18237431 Paper 18205889 Paper 17982457 Paper 17975299 Paper 17822919 Paper 17622780 Paper 17592628 Paper 17565751 Paper 17553421 Paper 17420321 Paper 17388942 Paper 17174556 Paper 17160894

Abstract

The goal of this project is to identify and evaluate candidate susceptibility genes for Parkinson disease (PD) using a mulfifactorial process we have termed "genomic convergence." This approach utilizes a number of different kinds of data, including genomic linkage analysis, gene expression profiles in PD patients as well as controls, biological activity of candidate genes, molecular analysis, and family-based association analysis. Several different brain tissues are severely affected in PD patients: the anterior olfactory nucleus is one of the first tissues to be affected in PD, the substantia nigra shows dramatic loss of dopaminergic neurons over the course of disease, and imaging studies of the putamen show defects in dopamine and nicotinic acetylcholine receptor binding. In this project, we will measure the level of gene expression in these tissues in order to identify candidate susceptibility genes for PD. We will also use laser capture microscopy to identify candidate genes by measuring gene expression in three different cell types within the substantia nigra: the dopaminergic neurons, non-pigmented neurons, and astroglial cells. Together with Project III, we will examine gene expression in cybrid cultures. Differentially expressed genes will then be prioritized in a variety of ways. First, we will identify those that map to regions of PD linkage. Second, we will evaluate the biological activity of genes to find those that are consistent with known metabolic defects in PD. This process of convergence will greatly reduce the number of genes that must be evaluated. We will then identify single nucleotide polymorphisms (SNPs) within or nearby these prioritized genes. Taqman assays will be developed for each of these SNPs, and they will be transferred to Core C for genotyping and Project I for analysis. Genes that show association with PD or interactions with other genes or the environment will be evaluated further for their role in PD.

View original record on NIH RePORTER →